Three new drugs approved by FDA.
Hoyt
Gerry
G
D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000069446:Atazanavir Sulfate; D003841:Deoxycytidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D000068679:Emtricitabine; D000077560:Enfuvirtide; D015700:HIV Envelope Protein gp41 / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D009842:Oligopeptides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D010446:Peptide Fragments / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D011725:Pyridines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D019380:Anti-HIV Agents; D015700:HIV Envelope Protein gp41; D009842:Oligopeptides; D010446:Peptide Fragments; D011725:Pyridines; D003841:Deoxycytidine; D000077560:Enfuvirtide; D000069446:Atazanavir Sulfate; D000068679:Emtricitabine